about
Azacitidine-induced cryptogenic organizing pneumonia: a case report and review of the literatureDiagnosis and management of drug-associated interstitial lung diseaseSurvival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumabPhase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer.Pulmonary toxicity related to systemic treatment of nonsmall cell lung cancer.A case of late-onset gemcitabine lung toxicityImpairments that influence physical function among survivors of childhood cancerSuccessful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report.High-resolution computed tomography findings for patients with drug-induced pulmonary toxicity, with special reference to hypersensitivity pneumonitis-like patterns in gemcitabine-induced cases.Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma--An Infrequent Event: Elucidation of Risk Factors and Management ImplicationsChemotherapy-induced infiltrative pneumonitis cases in breast cancer patients.Nivolumab: targeting PD-1 to bolster antitumor immunity.Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation.Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.Interstitial lung disease associated with gemcitabine: A Japanese retrospective cohort study.Gemcitabine-induced chronic systemic capillary leak syndromeSevere eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy.Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis.Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease.
P2860
Q28078522-35B20607-68B3-467F-8C24-F8C8BFBD43F9Q28212076-D6D54786-3157-4BE9-A4E9-74FA375481FEQ29620596-031A3441-6524-4980-8039-E374ED899206Q30313606-4E5E1E83-12CB-4820-82ED-BC7DF55C0E10Q34626688-1D19BC79-2264-48F3-9E31-E7A0E029257FQ35052548-8B7D9547-1FD4-44C3-A482-B602D6D2C96DQ35082766-B823521F-5F89-4BE8-BCC2-09CEDEFBEE8DQ36161839-A789A392-5531-4D69-BFAD-3A317EB0C674Q36804533-35D0EC1F-AA93-4C8F-908E-FF26DA41A808Q37168261-326BB91C-9E3E-4301-A25F-09ADEEE15F02Q37973172-88C0DB78-8BF4-4175-851A-B586D6979C9EQ38387311-127060DD-1465-449C-AE02-3A147964C3DBQ39537445-767C3EAF-10EB-4AEA-92E4-6060D4786A0BQ39564543-786C6799-7013-4E20-8EA2-5D4A96C6306AQ40099115-F3B18C48-A365-4456-BCB4-4B494D50FB9DQ41578489-D38B9F99-EB7F-4814-95B0-B594C03EEFC5Q41832345-C27C8507-4ABD-4A25-A661-3188466AA38FQ42225847-A2DE0AD3-B11B-4FB6-AB54-CFBCA0CD1738Q43078253-243A42B4-5A55-4090-815A-91B62D692203
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Gemcitabine-induced severe pulmonary toxicity.
@ast
Gemcitabine-induced severe pulmonary toxicity.
@en
type
label
Gemcitabine-induced severe pulmonary toxicity.
@ast
Gemcitabine-induced severe pulmonary toxicity.
@en
prefLabel
Gemcitabine-induced severe pulmonary toxicity.
@ast
Gemcitabine-induced severe pulmonary toxicity.
@en
P2093
P2860
P1476
Gemcitabine-induced severe pulmonary toxicity.
@en
P2093
Christophe Doddoli
Céline Gimenez
Fabrice Barlési
Jean-Pierre Kleisbauer
Patrick Villani
P2860
P356
10.1046/J.0767-3981.2003.00206.X
P577
2004-02-01T00:00:00Z